Local AstraZeneca jab ready by June

AstraZeneca vaccines for Covid-19 produced in Thailand will be ready for delivery to the government by June.

The Food and Drug Administration (FDA) has approved Siam Bioscience for manufacturing of the AstraZeneca's Covid-19 vaccine.

Shortly after the announcement, the Ministry of Public Health said that the first jabs would be given to the first group of 16 million people on June 7. The ministry needs to inoculate at least 70% of the population living in zones having a high level of infections in Bangkok, Chiang Mai and Chon Buri shortly to help slow down the spread of Covid-19.

A deputy public health minister said that the ministry has already set up criteria for the first group of 16 million people who are the first priority to get the vaccine. Their names have already been registered with the "Mor Prom" app which will be launched on May 1.

The 16 million people include 11.7 million aged over 60 and another 4.3 million suffering from chronic diseases.

The second phase of inoculation will be available for 31 million people aged between 18-59, who can register online in July. The vaccine will be ready for this group from August.

Learn from listening

Click play to listen to audio for this story, or download to save the file
: :

Vocabulary

  • chronic (adj): (of a disease, pain or problem) serious and lasting for a long time - เป็นประจำ
  • criteria: a standard that is used for judging something or for making a decision about something - บรรทัดฐาน
  • inoculate: to treat a person or animal with a vaccine to produce immunity against a disease -
  • inoculation (noun): an act of protecting a person or an animal from catching a particular disease by injecting them with a mild form of the disease - การฉีดวัคซีน,
  • jab: a vaccination - การฉีดวัคซีน
  • manufacturing (noun): making and producing a product - การผลิต
  • priority: something important that must be done first or which needs more attention than something else - การมาก่อน
Do you like the content of this article?
COMMENT
MORE IN SECTION